Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gentien

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|February 10, 2022
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histologyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
Molecular Oncology|March 13, 2013
Patient-derived xenografts recapitulate molecular features of human uveal melanomasCécile Laurent, David Gentien, Sophie Piperno-Neumann, et al.
Cancer Research|November 13, 2012
Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancerVirginie Maire, Fariba Némati, Marion Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenograftsPaul Cottu, Ivan Bièche, Franck Assayag, et al.
Cancer Research|December 8, 2010
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patientsCécile Laurent, Fabien Valet, Nathalie Planque, et al.
Cell Reports. Medicine|January 10, 2026
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancerPaul Cottu, Yann Kieffer, Jerome Lemonnier, et al.
Oncogene|March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networksHélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
Nature Genetics|May 29, 2019
The bipartite TAD organization of the X-inactivation center ensures opposing developmental regulation of Tsix and XistJoke G van Bemmel, Rafael Galupa, Chris Gard, et al.
Cancers|June 1, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal MelanomaLeanne de Koning, Didier Decaudin, Rania El Botty, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|February 10, 2022
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histologyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
Molecular Oncology|March 13, 2013
Patient-derived xenografts recapitulate molecular features of human uveal melanomasCécile Laurent, David Gentien, Sophie Piperno-Neumann, et al.
Cancer Research|November 13, 2012
Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancerVirginie Maire, Fariba Némati, Marion Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenograftsPaul Cottu, Ivan Bièche, Franck Assayag, et al.
Cancer Research|December 8, 2010
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patientsCécile Laurent, Fabien Valet, Nathalie Planque, et al.
Cell Reports. Medicine|January 10, 2026
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancerPaul Cottu, Yann Kieffer, Jerome Lemonnier, et al.
Oncogene|March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networksHélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
Nature Genetics|May 29, 2019
The bipartite TAD organization of the X-inactivation center ensures opposing developmental regulation of Tsix and XistJoke G van Bemmel, Rafael Galupa, Chris Gard, et al.
Cancers|June 1, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal MelanomaLeanne de Koning, Didier Decaudin, Rania El Botty, et al.
Pageof 9